Updated Jul 16, 2026
Sawicki Mark W is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $37K.

Mark W. Sawicki is the Chief Scientific Officer at Cryoport, Inc., a company specializing in temperature-controlled supply chain solutions for the life sciences industry. He has a strong background in scientific research and development, particularly in the fields related to biopharmaceuticals and cryogenic technologies.
| Role | Chief Scientific Officer |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | CYRX | Cryoport, Inc. | S — Open-market sale | 1.3K | $8.18 | $11K |
| 2026-03-18 | CYRX | Cryoport, Inc. | S — Open-market sale | 3.2K | $8.00 | $26K |
| 2026-03-18 | CYRX | Cryoport, Inc. | A — Grant or award | 22.8K | $0.00 |
Mark W. Sawicki is the Chief Scientific Officer at Cryoport, Inc., a company specializing in temperature-controlled supply chain solutions for the life sciences industry. He has a strong background in scientific research and development, particularly in the fields related to biopharmaceuticals and cryogenic technologies.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($37K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sawicki Mark W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.